Poly(carboxybetaine) nanomaterials enable long circulation and prevent polymer-specific antibody production

[1]  J. Hubbell,et al.  Drug development: longer-lived proteins. , 2012, Chemical Society reviews.

[2]  Yasuhiko Tabata,et al.  Blood clearance and biodistribution of polymer brush-afforded silica particles prepared by surface-initiated living radical polymerization. , 2012, Biomacromolecules.

[3]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[4]  Joseph M. DeSimone,et al.  Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.

[5]  U. Schubert,et al.  Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. , 2010, Angewandte Chemie.

[6]  Samir Mitragotri,et al.  Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. , 2010, Current pharmaceutical design.

[7]  Shaoyi Jiang,et al.  Ultralow‐Fouling, Functionalizable, and Hydrolyzable Zwitterionic Materials and Their Derivatives for Biological Applications , 2010, Advanced materials.

[8]  Parag Aggarwal,et al.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.

[9]  Daniel G. Anderson,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[10]  Parag Aggarwal,et al.  Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.

[11]  T. Ishida,et al.  Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. , 2008, International journal of pharmaceutics.

[12]  J. Hubbell,et al.  Functionalization of polysulfide nanoparticles and their performance as circulating carriers. , 2008, Biomaterials.

[13]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[14]  Taro Shimizu,et al.  PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[15]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[16]  Ji Guo,et al.  Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[17]  M. Dobrovolskaia,et al.  Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.

[18]  Herbert J Meiselman,et al.  Antibody against poly(ethylene glycol) adversely affects PEG‐asparaginase therapy in acute lymphoblastic leukemia patients , 2007, Cancer.

[19]  Horst A von Recum,et al.  Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery. , 2006, Macromolecular bioscience.

[20]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[21]  Shaoyi Jiang,et al.  Strong resistance of phosphorylcholine self-assembled monolayers to protein adsorption: insights into nonfouling properties of zwitterionic materials. , 2005, Journal of the American Chemical Society.

[22]  Robert Langer,et al.  Drugs on Target , 2001, Science.

[23]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[24]  Shuichi Takayama,et al.  Zwitterionic SAMs that Resist Nonspecific Adsorption of Protein from Aqueous Buffer. , 2001, Langmuir : the ACS journal of surfaces and colloids.

[25]  W. Oyen,et al.  Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. , 2000, The Journal of pharmacology and experimental therapeutics.

[26]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[27]  G. Whitesides,et al.  Self-assembled organic monolayers: model systems for studying adsorption of proteins at surfaces , 1991, Science.

[28]  Samir Mitragotri,et al.  Physical approaches to biomaterial design. , 2009, Nature materials.

[29]  Marek Langner,et al.  Repeated injections of PEG-PE liposomes generate anti-PEG antibodies. , 2005, Cellular & molecular biology letters.